Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections

A Ali, A Waris, MA Khan, M Asim, AU Khan, S Khan… - Life Sciences, 2023 - Elsevier
Emerging and re-emerging bacterial infections are a serious threat to human and animal
health. Extracellular bacteria are free-living, while facultative intracellular bacteria replicate …

[HTML][HTML] Regulation of CD8 T cell by B-cells: A narrative review

T Van Meerhaeghe, A Néel, S Brouard… - Frontiers in …, 2023 - frontiersin.org
Activation of CD4 T cells by B cells has been extensively studied, but B cell-regulated
priming, proliferation, and survival of CD8 T cells remains controversial. B cells express high …

[PDF][PDF] Vaccine adjuvant-elicited CD8+ T cell immunity is co-dependent on T-bet and FOXO1

DL Ivanova, SB Thompson, J Klarquist, MG Harbell… - Cell reports, 2023 - cell.com
T-bet and FOXO1 are transcription factors canonically associated with effector and memory
T cell fates, respectively. During an infectious response, these factors direct the development …

[HTML][HTML] IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort

TF Spracklen, SC Mendelsohn, C Butters… - Frontiers in …, 2022 - frontiersin.org
Introduction Multisystem inflammatory syndrome in children (MIS-C) is a severe acute
inflammatory reaction to SARS-CoV-2 infection in children. There is a lack of data describing …

Interferon α facilitates anti-HBV cellular immune response in a B cell-dependent manner

S Zhong, Q Li, C Wen, Y Li, Y Zhou, Z Jin, G Ye… - Antiviral Research, 2022 - Elsevier
Objectives Dissecting the underlying mechanism of T cells remodeling mediated by
interferon α (IFN-α) is indispensable for achieving an optimum therapeutic response in …

[HTML][HTML] Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab

E Groß-Albenhausen, A Weier, M Velten… - Frontiers in …, 2023 - frontiersin.org
Introduction Since the development of the coronavirus disease (COVID-19) pandemic
caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there has …

Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk

C Li, R Clauson, LF Bugada, F Ke, B He, Z Yu… - ACS …, 2024 - ACS Publications
Current cancer vaccines using T cell epitopes activate antitumor T cell immunity through
dendritic cell/macrophage-mediated antigen presentation, but they lack the ability to …

Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective

S Gu, L Qian, Y Zhang, K Chen, Y Li, J Wang… - Biochimica et Biophysica …, 2021 - Elsevier
Immunotherapy for cancer has provided new treatment approaches for malignant tumors,
but there are low rates of response and high rates of resistance. The most recent …

mRNA Vaccines Contribute to Innate and Adaptive Immunity to Enhance Immune Response In Vivo

Q Cao, H Fang, H Tian - Biomaterials, 2024 - Elsevier
Messenger RNA (mRNA) therapeutics have been widely employed as strategies for the
treatment and prevention of diseases. Amid the global outbreak of COVID-19, mRNA …

The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose

D Luque-Paz, P Sesques, F Wallet… - Expert Review of Anti …, 2022 - Taylor & Francis
Introduction Chimeric antigen receptor T (CAR-T) cell immunotherapy has revolutionized the
prognosis of refractory or relapsed B-cell malignancies. CAR-T cell recipients have …